EUVIMEDEUVIMED entdecken
Open Access

The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy

Xiya Guo, Yajuan Niu, Wang Han, Xiaoyu Han, Qing Chen, Si Tian, Ying Zhu, Dingqun Bai, Kaiting Li

International Journal of Oncology · 2023

DOI: 10.3892/ijo.2023.5503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Xiya Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China. Hauptthemen laut MEDLINE: Neovascularization, Pathologic, Photochemotherapy, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neovascularization, PathologicPhotochemotherapySignal TransductionHumansHuman Umbilical Vein Endothelial CellsInhibitor of Differentiation Protein 1NeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSmad ProteinsActivin Receptors, Type II

Stichwörter der Autor:innen

activin receptor‑like kinase‑1angiogenesisco‑culturephotodynamic therapytumour

Substanzen

Inhibitor of Differentiation Protein 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSmad ProteinsID1 protein, humanACVRL1 protein, humanActivin Receptors, Type II

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.

Zitieren

APA

Guo, X., Niu, Y., Han, W., Han, X., Chen, Q., Tian, S., Zhu, Y., Bai, D., & Li, K. (2023). The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5503

Vancouver

Guo X, Niu Y, Han W, Han X, Chen Q, Tian S, et al. The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5503

BibTeX
@article{Guo2023,
  author = {Guo, Xiya and Niu, Yajuan and Han, Wang and Han, Xiaoyu and Chen, Qing and Tian, Si and Zhu, Ying and Bai, Dingqun and Li, Kaiting},
  title = {The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy},
  journal = {International Journal of Oncology},
  year = {2023},
  doi = {10.3892/ijo.2023.5503}
}
Kostenlos starten →